Dr. Henick is a medical oncologist specializing in thoracic malignancies and experimental therapeutics. He studied Economics and health care delivery as an undergraduate at the University of Pennsylvania, and attended Rutgers-New Jersey Medical School where he was inducted to the Gold Humanism Honor Society. He completed his post-graduate training in Internal Medicine and Hematology/Medical Oncology at Yale-New Haven Hospital, where he studied the role of the innate immune system as a predictor of sensitivity or resistance to immunotherapy. He has presented his research, supported by Conquer Cancer Foundation/ASCO awards, at national conferences including ASCO. Dr. Henick’s goal as a clinician and researcher is to improve upon existing treatment strategies, personalizing each patient’s care through computational study of cancer immunobiology and by being attuned to their values and needs alongside CUMC’s dedicated multidisciplinary team.